BESSOR PHARMA, LLC SBIR Phase I Award, September 2023
A SBIR Phase I contract was awarded to BESSOR PHARMA, LLC in September, 2023 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like BESSOR PHARMA, LLC SBIR Phase I Award, September 2023
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.